From R&D Dark Matter
to Audit-Ready Intelligence
Your most valuable IP is trapped in handwritten batch records, thousand-page eCTD submissions, and non-standardised lab notebooks. Intics ADI transforms it into a sovereign, high-velocity strategic asset — without ever leaving your firewall.
For regulatory affairs, quality, and R&D leaders who need to move faster without compromising GxP compliance.
Pharma knowledge is
buried in “Dark Matter”
The average pharmaceutical company processes millions of documents per year — batch records in technical cursive, non-standardised lab notebooks, sprawling eCTD submissions. This data is your most valuable IP, yet it’s invisible to your systems, your auditors, and your leadership.
Clinical trial files, batch records, SOPs, and lab notes exist as static PDFs, scans, and handwritten forms. Senior scientists spend up to 30% of their time manually locating and re-keying data that already exists somewhere in your document estate.
Cloud-based AI services require your compound data, patient narratives, and formulation specifics to leave your perimeter. A single breach or vendor policy change can expose multi-billion dollar pipeline IP. “Rented AI” is an existential risk in pharma.
Semantic inconsistencies across eCTD modules — caught only at FDA/EMA review — result in months of delays and direct financial penalties. Manual cross-checking across thousand-page dossiers is error-prone and chronically understaffed.
As your document volumes grow — more trials, more markets, more products — your processing costs grow proportionally. You pay more precisely when your business is most active. This is a structural misalignment that owned infrastructure eliminates.
From ingestion to action — fully within your perimeter
Intics ADI operates as an intelligence layer on top of your existing TMF, ERP, and QMS systems. No rip-and-replace. No cloud dependency. No per-page fees.
Handwritten batch records, scanned lab notebooks, eCTD PDFs, CRFs, CSRs — any format, any quality, any language.
Radon, Xenon, and Krypton models — specifically trained on pharma document types — extract with clinical precision.
AI agents perform cross-document consistency checks: eCTD module cross-referencing, TMF reconciliation, MEDDRA coding.
Validated data feeds directly into your QMS, ERP, TMF, or regulatory submission platform via API or structured file.
Every extraction linked to source bounding box. Every agentic decision logged. Always audit-ready for 21 CFR Part 11.
Three models trained on
your document reality
General-purpose AI models fail on pharma documents because they were never trained on technical cursive, complex table structures, or regulatory filing conventions. Intics deploys domain-specific vision models built for the documents you actually have.
Trained on technical cursive, low-quality scans, and degraded originals. Reads batch records signed by laboratory technicians with the same precision as typed documents. The model that unlocks your “dark matter.”
Understands clinical intent within patient narratives, physician notes, and safety reports. Extracts adverse event signals, suspect drugs, and clinical symptoms — then cross-references MedDRA codes automatically.
Identifies table structure and spatial relationships within CMC dossiers, Certificates of Analysis, and regulatory filings. Maps extracted data to your internal taxonomy automatically.
Where Intics delivers measurable outcomes
Eight high-value workflows — from eCTD submission to pharmacovigilance — each with documented performance outcomes. Start with the one that has the most immediate impact on your pipeline.
Autonomous agents monitor TMF repositories (Veeva, SharePoint) in real time, performing semantic reconciliation against study protocol. “Always audit-ready” status — no manual TMF review cycles.
Cross-document consistency checks across all five eCTD modules before submission. Catches the semantic inconsistencies that cause Refusal to File — before you submit to FDA or EMA.
Xenon extracts patient data, suspect drugs, and clinical symptoms from adverse event reports. Cross-references MedDRA codes and auto-populates ICSR fields with 95%+ accuracy.
Technical cursive models digitise complex tables and signatures in batch records. Extracts specs, test results, and deviation records from CoAs for GMP compliance tracking.
Agents categorise quality events, identify deviation trends across your QMS, and draft initial CAPA investigation reports. Transforms reactive quality management into proactive oversight.
Digitises and semantically indexes decades of lab notes, allowing researchers to query compound interaction history across your entire R&D archive. Unlocks the “dark matter” of your pipeline.
Extracts GxP obligations and audit rights from vendor contracts. Flags non-conformances, tracks CAPAs, and mitigates third-party risk across your supply chain.
Extracts insights from field visit reports, KOL interaction records, and medical inquiry responses. Surfaces patterns across your medical affairs activity that would otherwise remain siloed.
Every Intics deployment is tuned to your specific document types, taxonomy, and downstream systems. Book a Dark Matter Discovery session to map your document estate.
See ADI process a batch record in real time
Watch Intics ingest a handwritten GMP batch record — technical cursive and all — and produce structured, audit-ready output in under 60 seconds. No pre-processing. No templates.
Interactive product demo also available — contact your Intics representative
Outcomes from production deployments
Results from anonymised enterprise pharma deployments across clinical operations, CMC, and pharmacovigilance workflows.
Stop paying a per-page tax on your own IP
As your pipeline grows — more trials, more markets, more products — your cloud processing costs grow in lockstep. Intics builds you a captive infrastructure where every additional document processed has near-zero marginal cost.
Your IP leaves the firewall on every call
Per-page fees scale with your pipeline success
Vendor policy risk on data handling
No institutional learning — model doesn’t improve on your data
Fully sovereign — data never leaves your perimeter
Fixed infrastructure — near-zero marginal cost per document
CapEx ownership — capitalise as an infrastructure asset
Continuous learning on your document estate
Built for the regulatory reality of pharma
Compliance is not a feature we added — it’s the architecture. Every Intics deployment in pharma is designed from the ground up to satisfy the most stringent regulatory scrutiny.
Full technical controls for electronic records and signatures: system-generated audit trails, user authentication and access controls, timestamped versioning, and immutable record storage. Every extraction is linked to its source document bounding box — providing the evidentiary chain an FDA auditor requires.
Intics is designed for the rigour of Good Clinical, Manufacturing, and Laboratory Practices. Agentic decisions are logged with full “chain of thought” reasoning for regulatory review. Human-in-the-loop review is built into the workflow for every flagged edge case — not retrofitted.
Intics supports fully sovereign, air-gapped installations for the most sensitive R&D environments. Patient PII is masked at the point of ingestion via field-level data protection. No patient data, compound data, or formulation specifics leave your defined perimeter — contractually and architecturally.
Intics processes and validates documents across 50+ regulatory jurisdictions — FDA, EMA, CDSCO, PMDA, and beyond. Regulatory intelligence agents monitor guidance updates across all active jurisdictions and trigger labelling reviews when changes affect your approved indications.
Questions your legal and compliance team will ask
Ready to discover what’s
trapped in your document estate?
The first step is a Dark Matter Discovery session — a structured 2-hour workshop to map your document estate, identify the highest-ROI workflows, and define your pilot scope.
Typical pilot launch: 3 weeks from discovery session